BE2013C036I2 - - Google Patents

Download PDF

Info

Publication number
BE2013C036I2
BE2013C036I2 BE2013C036C BE2013C036C BE2013C036I2 BE 2013C036 I2 BE2013C036 I2 BE 2013C036I2 BE 2013C036 C BE2013C036 C BE 2013C036C BE 2013C036 C BE2013C036 C BE 2013C036C BE 2013C036 I2 BE2013C036 I2 BE 2013C036I2
Authority
BE
Belgium
Application number
BE2013C036C
Other languages
French (fr)
Original Assignee
Sanofi Mature Ip
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34224354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE2013C036(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Mature Ip filed Critical Sanofi Mature Ip
Publication of BE2013C036I2 publication Critical patent/BE2013C036I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE2013C036C 2003-09-19 2013-06-13 BE2013C036I2 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0311016A FR2859996B1 (fr) 2003-09-19 2003-09-19 Solvat acetonique du dimethoxy docetaxel et son procede de preparation
PCT/FR2004/002344 WO2005028462A1 (fr) 2003-09-19 2004-09-16 Solvat acetonique du dimethoxy docetaxel et son procede de preparation

Publications (1)

Publication Number Publication Date
BE2013C036I2 true BE2013C036I2 (pl) 2023-12-14

Family

ID=34224354

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2013C036C BE2013C036I2 (pl) 2003-09-19 2013-06-13

Country Status (38)

Country Link
US (1) US7241907B2 (pl)
EP (1) EP1667986B1 (pl)
JP (1) JP5010279B2 (pl)
KR (1) KR101123588B1 (pl)
CN (1) CN100429207C (pl)
AR (1) AR045667A1 (pl)
AU (1) AU2004274212B2 (pl)
BE (1) BE2013C036I2 (pl)
BR (1) BRPI0414492A8 (pl)
CA (1) CA2539309A1 (pl)
CR (1) CR8292A (pl)
CY (2) CY1114575T1 (pl)
DK (1) DK1667986T3 (pl)
ES (1) ES2403149T4 (pl)
FR (1) FR2859996B1 (pl)
HK (1) HK1093340A1 (pl)
HR (1) HRP20130322T1 (pl)
HU (1) HUS1300025I1 (pl)
IL (1) IL174240A (pl)
LU (1) LU92172I2 (pl)
MA (1) MA28045A1 (pl)
ME (2) MEP11708A (pl)
MX (1) MXPA06002639A (pl)
MY (1) MY136668A (pl)
NO (2) NO335997B1 (pl)
NZ (1) NZ545835A (pl)
PA (1) PA8612401A1 (pl)
PE (1) PE20050870A1 (pl)
PL (1) PL1667986T3 (pl)
PT (1) PT1667986E (pl)
RS (2) RS20060189A (pl)
RU (1) RU2342373C2 (pl)
SI (1) SI1667986T1 (pl)
TN (1) TNSN06086A1 (pl)
TW (1) TWI382022B (pl)
UA (1) UA87115C2 (pl)
WO (1) WO2005028462A1 (pl)
ZA (1) ZA200602255B (pl)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100160653A1 (en) * 2006-03-21 2010-06-24 Dr. Reddy's Laboratories Ltd. Docetaxel polymorphs and processes
US7855591B2 (en) * 2006-06-07 2010-12-21 Atmel Corporation Method and system for providing a charge pump very low voltage applications
US7652522B2 (en) * 2006-09-05 2010-01-26 Atmel Corporation High efficiency low cost bi-directional charge pump circuit for very low voltage applications
US20080176958A1 (en) 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
FR2926551A1 (fr) 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
AU2013205442B2 (en) * 2008-01-17 2016-05-12 Aventis Pharma S.A. Crystalline forms of dimethoxy docetaxel and methods for preparing same
EP2331140B1 (en) 2008-08-11 2018-07-04 Nektar Therapeutics Multi-arm polymeric alkanoate conjugates
FR2945211A1 (fr) * 2009-05-06 2010-11-12 Sanofi Aventis Combinaison antitumorale comprenant la cabazitaxel et la capecitabine
EA024186B1 (ru) 2009-10-29 2016-08-31 Авентис Фарма С.А. Применение кабазитаксела в комбинации с преднизоном или преднизолоном для лечения рака простаты
CA2708489A1 (en) * 2009-10-29 2011-04-29 Aventis Pharma S.A. Use of cabazitaxel and a prednisone or a prednisolone in the treatment of prostate cancer
AU2015200149B2 (en) * 2009-10-29 2016-12-01 Aventis Pharma S.A. Novel antitumoral use of cabazitaxel
WO2012088445A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
JP2014514306A (ja) * 2011-04-12 2014-06-19 プラス・ケミカルス・エスアー 固体形態のカバジタキセル及びその製造方法
WO2013024495A1 (en) * 2011-08-18 2013-02-21 Dr. Reddys Laboratories Limited Pharmaceutical formulations of cabazitaxel
TWI526437B (zh) * 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
CN103906747A (zh) 2011-10-31 2014-07-02 台湾神隆股份有限公司 卡巴他赛及其中间体的制备方法
DE112012004569T5 (de) 2011-11-01 2014-08-14 Fresenius Kabi Oncology Ltd. Amorphe Form von Cabazitaxel und Verfahren zum Herstellen davon
ES2716799T3 (es) 2011-11-28 2019-06-17 Fresenius Kabi Oncology Ltd Forma cristalina de cabazitaxel y proceso para la preparación de la misma
JP6025861B2 (ja) 2011-12-13 2016-11-16 アベンティス・ファーマ・ソシエテ・アノニム カバジタキセルの結晶形およびこれを調製するための方法
WO2013111157A1 (en) * 2012-01-03 2013-08-01 Shilpa Medicare Limited Process for preparing amorphous cabazitaxel
SG11201404712UA (en) * 2012-02-10 2014-09-26 Aventis Pharma Sa New pediatric uses of cabazitaxel
US9394266B2 (en) 2012-03-08 2016-07-19 IVAX International GmbH Solid state forms of cabazitaxel and processes for preparation thereof
CN102675257B (zh) * 2012-05-10 2014-07-02 上海金和生物技术有限公司 一种卡巴他赛晶体及其制备方法
CN102746258B (zh) 2012-07-25 2015-02-04 重庆泰濠制药有限公司 卡巴他赛的结晶形式及其制备方法
CN104583189A (zh) 2012-07-31 2015-04-29 永信药品工业股份有限公司 非晶型的卡巴利他索
WO2014028704A1 (en) 2012-08-15 2014-02-20 Yung Shin Pharm. Ind. Co., Ltd. Stable pharmaceutical formulation of cabazitaxel
CN103664836B (zh) * 2012-09-20 2016-04-20 齐鲁制药有限公司 7β,10β-二甲氧基多西紫杉醇氘代丙酮合物的晶型A及其制备方法
US20140094432A1 (en) 2012-10-02 2014-04-03 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
CN103804323A (zh) * 2012-11-14 2014-05-21 上海希迈医药科技有限公司 一种卡巴他赛溶剂化物及其制备方法和应用
CN103058960B (zh) * 2012-12-12 2014-12-10 江苏奥赛康药业股份有限公司 卡巴他赛多晶型形式及其制备方法
EP2743264A1 (en) 2012-12-13 2014-06-18 INDENA S.p.A. New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN103910698B (zh) * 2012-12-30 2016-01-20 上海医药工业研究院 卡巴他赛丙酮合物及其结晶
CN103910696B (zh) * 2012-12-30 2016-01-20 上海医药工业研究院 卡巴他赛异丙醚合物及其结晶
EP2777691A1 (en) 2013-03-14 2014-09-17 Pharmachemie B.V. Taxoid - Purification of Liquid Excipients
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
CN104277014A (zh) * 2013-07-04 2015-01-14 北京新天宇科技开发有限公司 二甲氧基多西紫杉醇一丙酮化物的稳定转化物及其结晶形式、以及它们的制备方法
WO2015000165A1 (zh) * 2013-07-04 2015-01-08 北京新天宇科技开发有限公司 二甲氧基多西紫杉醇一丙酮化物的稳定转化物及其结晶形式、以及它们的制备方法
EP2865674A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. Crystalline solvate forms of Cabazitaxel
EP2865675A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. A crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN103601704B (zh) * 2013-11-22 2015-05-06 石家庄智恒医药科技有限公司 无定形卡巴他赛的制备
US20180311203A1 (en) 2015-01-12 2018-11-01 Emcure Pharmaceuticals Limited Liquid formulation of cabazitaxel
PL3258931T3 (pl) * 2015-02-17 2020-12-28 Erasmus University Medical Center Rotterdam Zastosowanie kabazitakselu w leczeniu nowotworu złośliwego prostaty
EP3093014A1 (en) * 2015-05-13 2016-11-16 Aventis Pharma S.A. Cabazitaxel and its use for treating cancer
US10188626B2 (en) 2015-11-03 2019-01-29 Cipla Limited Stabilized cabazitaxel formulations
EP3548487A4 (en) 2016-11-29 2020-04-29 Censa Pharmaceuticals Inc. POLYMORPHE SHAPE OF SEPIAPTERIN
US11072614B2 (en) 2016-11-29 2021-07-27 Ptc Therapeutics Mp, Inc. Polymorphs of sepiapterin and salts thereof
EP3675863A4 (en) 2017-09-01 2021-01-27 PTC Therapeutics MP, Inc. PHARMACEUTICAL COMPOSITION CONSISTING OF SEPIAPTERIN AND ITS USES
MX2020012979A (es) 2018-05-30 2021-04-29 Ptc Therapeutics Mp Inc Métodos para aumentar la exposición al plasma de sepiapterina.
WO2020249507A1 (en) 2019-06-11 2020-12-17 Indena S.P.A. Anhydrous crystalline form of cabazitaxel, a process for its preparation and pharmaceutical compositions containing it
EP3808345A1 (en) 2019-10-15 2021-04-21 Sanofi Mature IP Cabazitaxel in mcrpc patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent
EP3797834A1 (en) 2019-09-25 2021-03-31 Sanofi Mature IP Cabazitaxel in mcrpc patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766635A (en) * 1991-06-28 1998-06-16 Rhone-Poulenc Rorer S.A. Process for preparing nanoparticles
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
FR2745814B1 (fr) * 1996-03-06 1998-04-03 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2771092B1 (fr) 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides
US6346543B1 (en) * 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain
EP0982027A1 (en) * 1998-08-17 2000-03-01 Aventis Pharma S.A. Taxoid derivatives for treating abnormal cell proliferation of the brain
US6136989A (en) * 1998-12-30 2000-10-24 Phytogen Life Sciences, Incorporated Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material
US5969165A (en) * 1999-01-07 1999-10-19 508037 (Nb) Inc. Isolation and purification of paclitaxel and other related taxanes by industrial preparative low pressure chromatography on a polymeric resin column
AU761389B2 (en) * 1999-05-17 2003-06-05 Bristol-Myers Squibb Company Novel reaction conditions for the cleavage of silyl ethers in the preparation of paclitaxel (taxol) and paclitaxel analogues
CA2468953C (en) * 2001-11-29 2010-05-11 Daiichi Pharmaceutical Co., Ltd. Taxane derivative crystal and method for preparing the same

Also Published As

Publication number Publication date
HK1093340A1 (en) 2007-03-02
CN1849311A (zh) 2006-10-18
IL174240A (en) 2010-12-30
PT1667986E (pt) 2013-04-24
IL174240A0 (en) 2006-08-01
PE20050870A1 (es) 2005-11-21
NO335997B1 (no) 2015-04-20
CY2013016I1 (el) 2018-01-10
AU2004274212B2 (en) 2010-03-04
FR2859996B1 (fr) 2006-02-03
KR20060072147A (ko) 2006-06-27
BRPI0414492A8 (pt) 2019-01-15
AR045667A1 (es) 2005-11-02
FR2859996A1 (fr) 2005-03-25
LU92172I2 (fr) 2013-05-21
BRPI0414492A (pt) 2006-11-14
MA28045A1 (fr) 2006-07-03
SI1667986T1 (sl) 2013-05-31
WO2005028462A1 (fr) 2005-03-31
MEP11708A (en) 2010-06-10
MXPA06002639A (es) 2006-06-05
CN100429207C (zh) 2008-10-29
KR101123588B1 (ko) 2012-03-22
CY1114575T1 (el) 2016-10-05
MY136668A (en) 2008-11-28
RS54614B1 (en) 2016-08-31
PA8612401A1 (es) 2005-08-04
PL1667986T3 (pl) 2013-06-28
ES2403149T3 (es) 2013-05-14
RU2006113122A (ru) 2006-08-27
NZ545835A (en) 2009-10-30
DK1667986T3 (da) 2013-05-06
JP2007505866A (ja) 2007-03-15
HUS1300025I1 (hu) 2016-08-29
LU92172I9 (pl) 2019-01-03
CA2539309A1 (fr) 2005-03-31
RU2342373C2 (ru) 2008-12-27
CR8292A (es) 2008-10-15
ZA200602255B (en) 2007-07-25
ME00054B (me) 2011-02-10
CY2013016I2 (el) 2018-01-10
NO2015013I2 (no) 2015-04-22
JP5010279B2 (ja) 2012-08-29
US20050065138A1 (en) 2005-03-24
RS20060189A (en) 2008-06-05
NO2015013I1 (no) 2015-05-04
EP1667986B1 (fr) 2013-01-16
NO20061714L (no) 2006-04-19
EP1667986A1 (fr) 2006-06-14
TNSN06086A1 (en) 2007-10-03
TWI382022B (zh) 2013-01-11
HRP20130322T1 (en) 2013-07-31
UA87115C2 (ru) 2009-06-25
US7241907B2 (en) 2007-07-10
ES2403149T4 (es) 2013-06-24
AU2004274212A1 (en) 2005-03-31
TW200524891A (en) 2005-08-01

Similar Documents

Publication Publication Date Title
BE2015C007I2 (pl)
BE2014C055I2 (pl)
BE2014C027I2 (pl)
BE2014C003I2 (pl)
BE2013C075I2 (pl)
BE2013C069I2 (pl)
BE2013C067I2 (pl)
BE2013C038I2 (pl)
BE2013C036I2 (pl)
BE2011C030I2 (pl)
BE2015C005I2 (pl)
BE2012C053I2 (pl)
BE2015C024I2 (pl)
AU2002318342A1 (pl)
AU2003207787A1 (pl)
AU2002329412A1 (pl)
AU2002331433A1 (pl)
AU2002332887A1 (pl)
AU2002333044A1 (pl)
AU2002337949A1 (pl)
AU2002339901A1 (pl)
AU2002340206A1 (pl)
AU2002348177A1 (pl)
AU2002351829A1 (pl)
AU2002353888A1 (pl)